I'd like to connect with other members who work in the CLIA / LDT space. Interested in hearing what challenges and successes others experience, thoughts on the FDA proposed rule, and any other topics you're willing to share.
J. Jaskula
VP, QA/RA
Natera
------------------------------
Jackie Jaskula
Regulatory Affairs Manager
OrthoPediatrics
Warsaw, IN
USA
------------------------------